Glen Industries Share Price | Glen Industries Stock Screener
GLEN
Pharmaceuticals
Track Glen Industries share price live with TickJournal's free stock screener.
Check GLEN annual price range for the annual price range and momentum.
Use the Glen Industries stock screener below to analyse P/E ratio, market cap, quarterly results, and more. Record your trades in TickJournal's free trading journal and track your portfolio performance.
Glen Industries Market Cap
₹177.41 Cr.
GLEN P/E Ratio (TTM)
-
Glen Industries P/B Ratio
1.42
EPS (TTM)
₹10.37
Dividend Yield
-
Debt to Equity
2.13
GLEN 52 Week High
-
Glen Industries 52 Week Low
-
Operating Margin
-
Profit Margin
-
GLEN Revenue (TTM)
-
EBITDA
-
Net Income
-
Total Assets
₹214.00
Total Equity
₹59.00
Glen Industries Share Price Chart
Screen Glen Industries share price with an interactive chart. Analyse GLEN price trends and volatility across different timeframes.
Glen Industries Company Profile - Fundamental Screener
Screen Glen Industries company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics
for GLEN shares.
Sector
Healthcare
Industry
Pharmaceuticals
Sub-Sector
Pharmaceuticals
Segment
E
ISIN
INE0UMC01019
Glen Industries Balance Sheet Screener
Screen GLEN balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation
metrics.
| Item | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Assets | ||||
| Total Assets | 214 | 161 | 137 | 116 |
| Current Assets | 104 | 78 | 62 | 58 |
| Fixed Assets | 108 | 81 | 73 | 55 |
| Liabilities | ||||
| Total Liabilities | 0 | 0 | 0 | 0 |
| Current Liabilities | 56 | 40 | 41 | 41 |
| Non-Current Liabilities | 0 | 0 | 0 | 0 |
| Shareholders' Equity | ||||
| Total Equity | 59 | 46 | 36 | 23 |
| Share Capital | 18 | 6 | 6 | 6 |
| Reserves & Surplus | 41 | 40 | 31 | 17 |
Glen Industries Income Statement Screener - Profit & Revenue Analysis
Screen Glen Industries income statement and profit fundamentals.
Analyze GLEN quarterly results,
revenue growth, EBITDA, net profit margins, and EPS using TickJournal's fundamental screener for Glen Industries share price evaluation.
| Item | None-None | 2025-March | 2024-March | 2023-March | 2022-March |
|---|---|---|---|---|---|
| Revenue | 0 | 171 | 145 | 120 | 97 |
| Expenses | 0 | 130 | 120 | 103 | 83 |
| EBITDA | 0 | 41 | 25 | 17 | 14 |
| Operating Profit % | 0.00% | 24.00% | 17.00% | 14.00% | 12.00% |
| Depreciation | 0 | 7 | 6 | 6 | 5 |
| Interest | 0 | 9 | 7 | 6 | 4 |
| Profit Before Tax | 0 | 24 | 11 | 3 | 5 |
| Tax | 0 | 6 | 3 | 1 | 1 |
| Net Profit | 0 | 18 | 9 | 2 | 4 |
| EPS | 0.00 | 10.37 | 82.42 | 0.85 | 2.09 |
Glen Industries Cash Flow Screener - Liquidity Fundamentals
Screen GLEN cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price
strength assessment.
| Item | 2025-March | 2024-March | 2023-March | 2022-March |
|---|---|---|---|---|
| Operating Activities | 6 | 14 | 11 | -14 |
| Investing Activities | -35 | -13 | -15 | -22 |
| Financing Activities | 30 | -2 | 4 | 34 |
| Net Cash Flow | 1 | -1 | 0 | -2 |
Glen Industries Shareholding Pattern Screener
See Glen Industries shareholding pattern with promoter, FII, and DII holdings.
Check Glen Industries promoter holding and ownership changes for GLEN on TickJournal.
| Item | 2026-Mar | 2025-Jun | 2025-Jul | 2025-Sept | 2024-Dec |
|---|---|---|---|---|---|
| Promoter Holding | 73.31% | 73.00% | 73.00% | 73.00% | 100.00% |
| FII Holding | 0.00% | 1.83% | 1.83% | 0.22% | 0.00% |
| DII Holding | 6.64% | 9.93% | 9.93% | 9.06% | 0.00% |
| Govt Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public Holding | 15.47% | 11.95% | 11.95% | 12.31% | 0.00% |
| Other Holding | 4.57% | 3.29% | 3.29% | 5.41% | 0.00% |
| Shareholder Count | 1,118 | 1,267 | 7 | 1,196 | 7 |
Glen Industries Share Dividend Screener - Share Yield Analysis
Check Glen Industries dividend history with payout and yield data.
View Glen Industries dividend details including ex-dates and amounts for GLEN stock.
Glen Industries Stock Index Membership
See which indices include Glen Industries stock.
Check GLEN index membership in NIFTY 50, SENSEX, and other indices on TickJournal.
Glen Industries Market Events Screener - Corporate Actions
Get Glen Industries corporate actions including splits, bonuses, and buybacks.
Check Glen Industries stock events that may affect GLEN share price.
| Announcement Date | Record Date | Event Type | Information | Price Impact |
|---|---|---|---|---|
| Annual General Meeting | NA | -5.52% | ||
| 2025-11-04 | 2025-11-04 | Quarterly Result Announcement | NA | 0.95% |
Glen Industries Competitors Screener - Peer Comparison
Screen GLEN competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance for better
stock selection.
| Company | Market Cap | P/E Ratio | Revenue | YoY Growth | Net Profit | RSI |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical | 450,643 | 40.81 | 54,729 | 9.71% | 10,980 | 64.89 |
| Divis Laboratories | 179,470 | 74.13 | 9,712 | 18.67% | 2,191 | 64.06 |
| Torrent Pharmaceuticals | 149,109 | 65.68 | 11,539 | 6.99% | 1,911 | 58.52 |
| Cipla | 115,682 | 30.09 | 27,712 | -2.46% | 3,783 | 69.78 |
| Dr Reddys Laboratories | 111,567 | 26.16 | 33,593 | -0.44% | 3,998 | 59.87 |
| Lupin | 104,032 | 19.28 | 27,488 | 19.98% | 5,345 | 46.11 |
| Mankind Pharma | 103,325 | 56.36 | 12,744 | 20.90% | 2,007 | 73.37 |
| Zydus Life Science | 101,801 | 19.85 | 23,511 | 18.55% | 4,615 | 69.47 |
| Aurobindo Pharma | 87,806 | 25.16 | 32,346 | 9.43% | 3,484 | 73.83 |
| Laurus Labs | 71,455 | 79.78 | 6,813 | 21.03% | 884 | 80.26 |
Glen Industries Company Announcements - News Screener
Screen GLEN latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis.
| Date | Update | Actions |
|---|---|---|
| 2026-05-18 | Compliances-Reg.24(A)-Annual Secretarial Compliance | - |
| 2026-05-18 | Regulation 32 Monitoring Agency Report | - |
| 2026-04-09 | Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 | - |
| 2026-04-09 | Announcement Under Regulation 30(LODR)- Business Update | - |
| 2026-03-30 | Announcement under Regulation 30 (LODR)-Updates on Acquisition | - |
| 2026-03-30 | Closure of Trading Window | - |
| 2026-03-28 | Announcement under Regulation 30 (LODR)-Updates on Acquisition | - |
| 2026-03-25 | Announcement under Regulation 30 (LODR)-Updates on Acquisition | - |
| 2026-03-24 | Announcement under Regulation 30 (LODR)-Updates on Acquisition | - |
| 2026-03-23 | Announcement under Regulation 30 (LODR)-Updates on Acquisition | - |
| 2026-03-20 | Announcement under Regulation 30 (LODR)-Updates on Acquisition | - |
| 2026-03-19 | Announcement under Regulation 30 (LODR)-Updates on Acquisition | - |
| 2026-03-18 | Announcement under Regulation 30 (LODR)-Updates on Acquisition | - |
| 2026-02-24 | Intimation Of Outcome Of Analysts/Investors Meeting | - |
| 2026-02-19 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation | - |
| 2026-02-10 | Quarterly Commentary - Standalone Sales Performance And Project Progress Update | - |
| 2026-01-30 | Intimation Under Regulation 30 Read With Schedule III Part A And Para B Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 | - |
| 2026-01-14 | Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 | - |
| 2025-12-06 | Intimation Of Outcome Of Analysts/Investors Meeting | - |
| 2025-12-03 | Intimation Of Outcome Of Analysts/Investors Meeting | - |